Tackling Antimicrobial Resistance (AMR)
The Australian Government is investing in research to help tackle the threat of microorganisms such as bacteria, viruses or parasites becoming resistant to standard medical treatments.
What we’re funding
The Australian Government will invest $5.9 million in research to help tackle the threat of antimicrobial resistance (AMR) in aged care facilities.
The purpose of this research funding is to:
- better understand the impact patient movement has on AMR in residential aged care facility settings
- develop new methods and approaches to prevent, detect and respond to AMR.
This funding supports research into:
- addressing knowledge gaps on antimicrobial resistance in residential aged care facilities
- novel technologies to explore the use of whole genome sequencing of bacteria to determine resistance profiles and how they change in response to different treatments and behaviours
- accelerated development of new interventions and approaches to prevent, detect and respond to resistance.
Why it’s important
- Antimicrobial resistance is an increasing problem in Australia and world wide.
- There are few remaining treatment options for some infections.
- New research investment is needed to ensure existing antimicrobials are still effective and we develop new treatment options.
How to apply
Applications for this program are closed.